In vitro and in vivo repair activities of undifferentiated and classically and alternatively activated macrophages

Pathobiology

Volumn 81, Issue 2, 2014, Pages 86-93

  Enderlin Vaz Da Silva, Zoé ^a   Lehr, Hans Anton ^b   Velin, Dominique ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Institute of Pathology   (Germany)

Author keywords

Colitis; Dextran sodium sulfate; Macrophages; Wound healing

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 4;

ALTERNATIVELY ACTIVATED MACROPHAGE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL TRANSFER; CLASSICALLY ACTIVATED MACROPHAGE; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; EPITHELIZATION; FEMALE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULCER HEALING; UNDIFFERENTIATED MACROPHAGE; WOUND CLOSURE; WOUND HEALING; ANIMAL EXPERIMENT;

MUS;

ANIMALS; BALB 3T3 CELLS; CELL DIFFERENTIATION; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 84896731974     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000357306     Document Type: Article

References (25)

1. Leibovich SJ, Ross R: The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
2. Mirza R, DiPietro LA, Koh TJ: Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009; 175: 2454-2462.
3. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A, Eming SA: Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010; 184: 3964-3977.
4. Brancato SK, Albina JE: Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol 2011; 178: 19-25.
5. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO: Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107: 1643-1652.
6. Qualls JE, Kaplan AM, van Rooijen N, Cohen DA: Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukocyte Biol 2006; 80: 802-815.
7. Bernasconi E, Favre L, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Croze E, Velichko S, Parkinson J, Michetti P, Velin D: Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflammy Bowel Dis 2010; 16: 428-441.
8. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
9. Fleming BD, Mosser DM: Regulatory macrophages: setting the threshold for therapy. Eur J Immunol 2011; 41: 2498-2502.
10. Varesio L, Blasi E, Thurman GB, Talmadge JE, Wiltrout RH, Herberman RB: Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res 1984; 44: 4465-4469.
11. Murray HW, Spitalny GL, Nathan CF: Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. J Immunol 1985; 134: 1619-1622.
12. Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
13. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE: Il-4 dependent alternatively- activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 2002; 3: 7.
14. Witte MB, Barbul A: Arginine physiology and its implication for wound healing. Wound Repair Regen 2003; 11: 419-423.
15. D'Angelo F, Bernasconi E, Schafer M, Moyat M, Michetti P, Maillard MH, Velin D: Macrophages promote epithelial repair through hepatocyte growth factor secretion. Clin Exp Immunol 2013; 174: 60-72.
16. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P: Interleukin-17 is a critical mediator of vaccine- induced reduction of helicobacter infection in the mouse model. Gastroenterology 2009; 136: 2237-2246.e2231.
17. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S: The Jmjd3- Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010; 11: 936-944.
18. Hunter MM, Wang A, Parhar KS, Johnston MJ, Van Rooijen N, Beck PL, McKay DM: In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 2010; 138: 1395-1405.
19. Vongsa RA, Zimmerman NP, Dwinell MB: CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells. J Biol Chem 2009; 284: 10034-10045.
20. Nagai M, Takahashi N, Miyazawa K, Kawaguchi M, Chijiiwa K, Kataoka H: Activation of met receptor tyrosine kinase in ulcer surface epithelial cells undergoing restitution. Pathol Int 2008; 58: 462-464.
21. Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE: The phenotype of murine wound macrophages. J Leukocyte Biol 2010; 87: 59-67.
22. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22: 317-326.
23. Danon D, Kowatch MA, Roth GS: Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA 1989; 86: 2018-2020.
24. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, Harris DC: Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007; 72: 290-299.
25. Rieder F, Karrasch T, Ben-Horin S, Schirbel A, Ehehalt R, Wehkamp J, de Haar C, Velin D, Latella G, Scaldaferri F, Rogler G, Higgins P, Sans M: Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. J Crohns Colitis 2012; 6: 373-385.